Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2069614
Max Phase: Preclinical
Molecular Formula: C53H74N8O8
Molecular Weight: 951.22
Molecule Type: Small molecule
Associated Items:
ID: ALA2069614
Max Phase: Preclinical
Molecular Formula: C53H74N8O8
Molecular Weight: 951.22
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCCCNC(=O)C[C@H](O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)c1ccc(Oc2ccc(C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)NCCCNc3ccnc4ccccc34)cc2)cc1)[C@@H](C)CC
Standard InChI: InChI=1S/C53H74N8O8/c1-9-11-26-56-47(63)32-46(62)44(30-33(3)4)59-53(68)48(35(7)10-2)61-51(66)38-19-23-40(24-20-38)69-39-21-17-37(18-22-39)50(65)60-45(31-34(5)6)52(67)58-36(8)49(64)57-28-14-27-54-43-25-29-55-42-16-13-12-15-41(42)43/h12-13,15-25,29,33-36,44-46,48,62H,9-11,14,26-28,30-32H2,1-8H3,(H,54,55)(H,56,63)(H,57,64)(H,58,67)(H,59,68)(H,60,65)(H,61,66)/t35-,36-,44-,45-,46-,48-/m0/s1
Standard InChI Key: CVZBLBBXIMVEQC-UQNYQZROSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 951.22 | Molecular Weight (Monoisotopic): 950.5630 | AlogP: 6.64 | #Rotatable Bonds: 28 |
Polar Surface Area: 228.98 | Molecular Species: NEUTRAL | HBA: 10 | HBD: 8 |
#RO5 Violations: 3 | HBA (Lipinski): 16 | HBD (Lipinski): 8 | #RO5 Violations (Lipinski): 4 |
CX Acidic pKa: 12.28 | CX Basic pKa: 8.16 | CX LogP: 5.59 | CX LogD: 4.86 |
Aromatic Rings: 4 | Heavy Atoms: 69 | QED Weighted: 0.03 | Np Likeness Score: -0.28 |
1. Vaiana N, Marzahn M, Parapini S, Liu P, Dell'Agli M, Pancotti A, Sangiovanni E, Basilico N, Bosisio E, Dunn BM, Taramelli D, Romeo S.. (2012) Antiplasmodial activities of 4-aminoquinoline-statine compounds., 22 (18): [PMID:22884991] [10.1016/j.bmcl.2012.07.069] |
Source(1):